A Biotech micro cap just announced that it has doubled the initial production run totals for its Delta 8 Tetrahydrocannabinol ("Delta 8 THC") infused version of Tauri-Gum™ (ninth overall product line SKU). The press release went on to say that this produce version is infused with 10 mg of Delta 8 THC per piece of chewing gum. Shares of Tauriga Sciences Inc. (OTCQB:TAUG) rallied on the news.
Tauriga is a revenue generating company that operates through the development, distribution, and licensing of proprietary products as well as evaluation of potential acquisition opportunities. One such opportunity on which the company has acted involves the company having entered into the cannabidiol (or CBD) infused chewing gum product business. This CBD infused chewing gum product has been branded under Tauri-Gum.
Traders were bullish on the announcement as shares hit $0.0999/share at the high. The stock has been in somewhat of a lull since the open of this year, starting the year around $0.17/share.
